Abstract:OBJECTIVE:To explore the association between serum inflammation levels and cognitive function in patients with obstructive sleep apnea-hypopnea syndromes (OSAHS) and evaluate the effects of continuous positive airway pressure treatment (CPAP) on serum inflammation levels and cognitive function. METHODS:A total of 139 eligible patients were monitored by overnight polysomnography (PSG) at Sleep Center, Second Affiliated Hospital, Soochow University from June 2011 to April 2013. Based on the results of apnea-hypopnea index (AHI), they were divided into 4 groups of primary snoring (n = 18), mild OSAHS(n = 23), moderate OSAHS (n = 29) and severe OSAHS (n = 69). The questionnaires of Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE) and Epworth Sleepiness Scale (ESS) were administered to assess cognitive function and daytime sleepiness. The serum levels of high-sensitivity C-reactive protein (Hs-CRP), leptin and tumor necrosis factor alpha (TNF-α) were detected to evaluate systemic inflammation. The questionnaire scores, serum levels of Hs-CRP, leptin and TNF-α and PSG parameters were compared among 4 groups. Thirty-three patients in severe OSAHS group (treatment group) with good adherence were evaluated at baseline and after long-time CPAP treatment. RESULTS:Compared to primary snoring group, the serum Hs-CRP ((1.77 ± 1.19) vs (0.92 ± 0.82) mg/L), leptin ((15.21 ± 13.26) vs (6.35 ± 4.51) mmol/L) and TNF-α ((21.04 ± 7.78) vs (10.30 ± 5.23) pmol/L) levels increased significantly in severe OSAHS group (P < 0.05). After adjusting for body mass index (BMI), age and education years, MoCA scores showed negative correlations with serum TNF-α, AHI, oxygen reduction index (ODI) and TS90% (r = -0.266, -0.236, -0.201, -0.18 respectively, all P < 0.05) and positive correlations with minimum oxygen saturation (LSaO(2)) (r = 0.224, P < 0.05). The evaluations of MoCA subdomains further revealed selective reductions in visual space, executive function, attention and delayed memory function. The treatment group with good adherence to > 6-month continuous positive airway pressure (CPAP) treatment and after CPAP treatment, the serum levels of Hs-CRP, TNF-α and leptin improved markedly ((1.20 ± 0.88) vs (2.03 ± 1.58) mg/L, (14.12 ± 4.34) vs (22.74 ± 6.72) pmol/L and (7.37 ± 5.30) vs (13.69 ± 7.17) mmol/L respectively). The scores of MoCA and ESS also improved (27.79 ± 1.69 vs 24.76 ± 2.57, 4.33 ± 3.14 vs 12.61 ± 5.80 respectively) (all P < 0.01). The score of all MoCA subdomains improved after treatment. CONCLUSIONS:Cognitive dysfunction and inflammatory reaction are common in OSAHS patients. MoCA scores are correlated significantly with serum level of TNF-α and nocturnal intermittent hypoxia. Systemic inflammation may play an important role in cognitive dysfunction of OSAHS patients. And long-time CPAP treatment can improve systemic inflammatory response and cognitive impairment.

Effect of continuous positive airway pressure treatment on Th17/Treg imbalance in patients with obstructive sleep apnea and a preliminary study on its mechanism

Effect of Continuous Positive Air Pressure on Cognitive Impairment Associated with Obstructive Sleep Apnea.

[Role and Mechanism of Th17/Treg in Obstructive Sleep Apnea Hypopnea Syndrome].

[Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].

Effects of Continuous Positive Airway Pressure on C-reactive Protein and Interleukin-6 in Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension

Effects of Continuous Positive Airway Pressure on Serum Inflammatory Factors in Coronary Heart Disease Patients Complicated with Obstructive Sleep Apnea-Hypopnea Syndrome

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

Continuous Positive Airway Pressure Effectively Ameliorates Arrhythmias in Patients with Obstructive Sleep Apnea-Hypopnea Via Counteracting the Inflammation

The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome.

Effects of Continuous Positive Airway Pressure on Neurocognitive Architecture and Function in Patients with Obstructive Sleep Apnoea: Study Protocol for A Multicentre Randomised Controlled Trial

Effects of Continuous Positive Airway Pressure on Adhesion Molecules and P-selectin in Coronary Heart Disease Patients with Obstructive Sleep Apnea Syndrome

Improvement on Inflammation and Insulin Resistance after Continuous Positive Airway Pressure in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Hypopnea Syndrome

Effect of continuous positive airway pressure on blood ICAM-1 in obstructive sleep apnea syndrome patients

Effect of Continuous Positive Airway Pressure on Lipid Profiles in Obstructive Sleep Apnea: A Meta-Analysis

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Effect of Continuous Positive Airway Pressure on Cardiometabolic Risk Factors in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

Impact of Upper Airway Characteristics on Disease Severity and CPAP Therapy in Chinese Patients With OSA: An Observational Retrospective Study

Effect of Cpap Therapy on C-Reactive Protein and Cognitive Impairment in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Study of the Effect of Nasal Continual Positive Airway Pressure on Serum Levels of TNF‐α and IL‐6 in OSAHS Patients

Effect of continuous positive airway pressure therapy on blood pressure variability of obstructive sleep apnea hypopnea syndrome

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].